South & Central America Rapid Test Kit Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), and End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others)

No. of Pages: 145    |    Report Code: BMIRE00030560    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Rapid Test Kit Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Rapid Test Kit Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Rapid Test Kit Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. South & Central America Rapid Test Kit Market Regional Analysis

6.1 South & Central America Rapid Test Kit Market Overview
6.2 South & Central America Rapid Test Kit Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Rapid Test Kit Market Forecast Analysis

7. South & Central America Rapid Test Kit Market Analysis – by Type

7.1 Rapid Antigen Testing
  • 7.1.1 Overview
  • 7.1.2 Rapid Antigen Testing: South & Central America Rapid Test Kit Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Rapid Antibody Testing
  • 7.2.1 Overview
  • 7.2.2 Rapid Antibody Testing: South & Central America Rapid Test Kit Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Rapid Test Kit Market Analysis – by Product

8.1 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit
  • 8.1.1 Overview
  • 8.1.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: South & Central America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Rapid Test Kit Market Analysis – by Application

9.1 Blood Glucose Testing
  • 9.1.1 Overview
  • 9.1.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: South & Central America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Infectious Disease Testing
  • 9.2.1 Overview
  • 9.2.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: South & Central America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Pregnancy and Fertility
  • 9.3.1 Overview
  • 9.3.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: South & Central America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
  • 9.4.1 Overview
  • 9.4.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: South & Central America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Rapid Test Kit Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Rapid Test Kit Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 South & Central America Rapid Test Kit Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Rapid Test Kit Market Breakdown, by Type
    • 10.1.1.1.2 Brazil: South & Central America Rapid Test Kit Market Breakdown, by Product
    • 10.1.1.1.3 Brazil: South & Central America Rapid Test Kit Market Breakdown, by Application
  • 10.1.1.2 Argentina: South & Central America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Rapid Test Kit Market Breakdown, by Type
    • 10.1.1.2.2 Argentina: South & Central America Rapid Test Kit Market Breakdown, by Product
    • 10.1.1.2.3 Argentina: South & Central America Rapid Test Kit Market Breakdown, by Application
  • 10.1.1.3 Rest of South and Central America : South & Central America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Rapid Test Kit Market Breakdown, by Type
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Rapid Test Kit Market Breakdown, by Product
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Rapid Test Kit Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Rapid Test Kit Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Becton Dickinson and Co
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 ARKRAY Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Fujirebio Europe NV
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 bioMerieux SA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Cepheid
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 QIAGEN NV
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Guangzhou Wondfo Biotech Co Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Abbott Laboratories
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Trinity Biotech Plc
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Bio-Rad Laboratories Inc
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments
13.13 Hologic Inc
  • 13.13.1 Key Facts
  • 13.13.2 Business Description
  • 13.13.3 Products and Services
  • 13.13.4 Financial Overview
  • 13.13.5 SWOT Analysis
  • 13.13.6 Key Developments
13.14 Premier Medical Corp Pvt Ltd
  • 13.14.1 Key Facts
  • 13.14.2 Business Description
  • 13.14.3 Products and Services
  • 13.14.4 Financial Overview
  • 13.14.5 SWOT Analysis
  • 13.14.6 Key Developments
13.15 DiaSorin SpA
  • 13.15.1 Key Facts
  • 13.15.2 Business Description
  • 13.15.3 Products and Services
  • 13.15.4 Financial Overview
  • 13.15.5 SWOT Analysis
  • 13.15.6 Key Developments
13.16 Beckman Coulter Inc
  • 13.16.1 Key Facts
  • 13.16.2 Business Description
  • 13.16.3 Products and Services
  • 13.16.4 Financial Overview
  • 13.16.5 SWOT Analysis
  • 13.16.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - S Market

1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. Guangzhou Wondfo Biotech Co Ltd
10. Abbott Laboratories
11. Trinity Biotech Plc
12. Bio-Rad Laboratories Inc
13. Hologic Inc
14. Premier Medical Corp Pvt Ltd
15. DiaSorin SpA
16. Beckman Coulter Inc